thiazolyl blue has been researched along with praziquantel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, C; Mao, R; Sun, D; Sun, Q; Wang, D; Zheng, Y | 1 |
| Couri, MRC; de Moraes, J; Enes, KB; Espírito-Santo, MCC; Mengarda, AC; Miguel, FB; Morais, CS; Rodrigues, VC; Siyadatpanah, A; Wilairatana, P | 1 |
2 other study(ies) available for thiazolyl blue and praziquantel
| Article | Year |
|---|---|
The cytotoxicity study of praziquantel enantiomers.
Topics: Cell Line, Tumor; Hep G2 Cells; Humans; L-Lactate Dehydrogenase; Praziquantel; Schistosomiasis; Stereoisomerism; Tetrazolium Salts; Thiazoles | 2016 |
Pyrazoline derivatives as promising novel antischistosomal agents.
Topics: Animals; Antiparasitic Agents; Chalcones; Chemistry, Pharmaceutical; Chlorocebus aethiops; Computer Simulation; Drug Discovery; Haplorhini; Humans; Mice; Praziquantel; Pyrazoles; Schistosoma mansoni; Schistosomiasis mansoni; Schistosomicides; Solvents; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles; Vero Cells | 2021 |